Hepatocyte Growth Factor: Clinical Trials

5 trials of Hepatocyte Growth Factor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 withdrawn. 2 Phase 2, 2 Phase 3, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Withdrawn 1
Phase 32Active not recruiting 1, Unknown 1
Phase 11Completed 1
Phase 41Unknown 1

Follow Hepatocyte Growth Factor: new trials by email Literature Review of Hepatocyte Growth Factor trials Research Report on Hepatocyte Growth Factor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar
KP-100LI, Placebo - Vocal Fold Scar
Phase 3Active not recruitingKringle Pharma, Inc.622022-12-012026-07-06
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia
Avatrombopag, Standard medical treatment - Liver Failure, Thrombocytopenia
Phase 4UnknownTongji Hospital1502021-02-012021-06-07
Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
KP-100IT - Acute Spinal Cord Injury
Phase 3UnknownKringle Pharma, Inc.252020-07-132022-08-26
Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea
Stage 1-Low dose VM202RY, Stage 1-Middle dose VM202RY, Stage 1-High dose VM202RY - Ischemic Heart Disease, Acute Myocardial Infarction
Phase 2WithdrawnHelixmith Co., Ltd.2018-01-252025-09-25
Phase I/II Study of KP-100IT in Acute Spinal Cord Injury
KP-100IT, Placebo - Spinal Cord Injuries
Phase 1 / Phase 2CompletedKringle Pharma, Inc.452014-06-302019-06-05

Conditions studied

Deafness, Autosomal Recessive 39 (3)  ·  End Stage Liver Disease (1)  ·  Liver Failure (1)  ·  Myocardial Ischemia (1)  ·  Spinal Cord Injuries (1)  ·  Thrombocytopenia (1)

Sponsors

Kringle Pharma, Inc. (3)  ·  Helixmith Co., Ltd. (1)  ·  Tongji Hospital (1)

Countries

Japan (3)  ·  China (1)  ·  South Korea (1)

Top investigators

Daichika Hayata (1)  ·  Etsuro Hashimura (1)  ·  Qin Ning, MD., PhD. (1)  ·  Wook Bum Pyun, MD, PhD (1)